HCPCS Level II › J codes

`J0791` Inj crizanlizumab-tmca 5mg

Injection, crizanlizumab-tmca, 5 mg

Medicare coverage: Carrier judgment
Status: active (July 2026 file)
MUE: max 160 units per day (practitioner), rationale: CMS Policy